Get research updatesDepression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
Financial Incentives for Therapy Completion: A Randomized Controlled Trial With U.S. Veterans
This study is by invitation only.
Multiple locations, including Dallas
Lemborexant for the Treatment of Residual Insomnia in Adequately Treated Major Depressive Disorder: A Pilot Randomized Controlled Trial
This study ended early.
In Toronto
Safety and Efficacy of an Accelerated, Rectangular Waveform rTMS Protocol in Treatment of Adults With Major Depressive Disorder
This study has finished and is no longer accepting participants.
In San JoseSSRI Versus Bupropion in High-Risk Major Depressive Disorder
This study has finished and is no longer accepting participants.
In New York
Psychiatric Genotype/Phenotype Project
This study is by invitation only.
In NashvilleSAINT® Neuromodulation System for the Treatment of Depression in an Inpatient Setting
This study ended early.
Multiple locations, including Iowa CityExploratory Clinical Study to Investigate the Therapeutic Mechanisms, Efficacy Prediction, and Safety Profile of Individualized Transcranial Magnetic Stimulation as a Therapeutic Intervention in Adult Participants Diagnosed With Irritable Bowel Syndrome, Utilizing Multimodal Magnetic Resonance Imaging for Neuroimaging Assessment and High-Throughput Sequencing for Fecal Microbiota Analysis and Metabolic Profile Detection
This study is by invitation only.
In HangzhouResearchers compared Ropanicant and placebo to find out how the approaches affected depression symptoms in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockAn open-label feasibility study of ketamine-assisted therapy in adults with treatment-resistant depression.
This study has finished and is no longer accepting participants.
In New ZealandOptimizing the clinical effectiveness of dual site Theta Burst Stimulation (TBS) treatment for individuals with treatment-resistant depression (OPTI-TBS; Study 2)
This study was withdrawn before enrollment.
In AustraliaOptimizing the clinical effectiveness of Theta Burst Stimulation (TBS) treatment for individuals with treatment-resistant depression (OPTI-TBS; Study 1 )
Recruitment is currently suspended.
In AustraliaAn open-label clinical trial of oral ketamine, an NMDA (N-methyl-D-aspartate) receptor antagonist on depressive symptomatology in people aged 16 years and older who are experiencing treatment-resistant depression.
This study ended early.
In AustraliaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.